* Core Laboratories Inc CLB.N CLB is expected to show a
rise
in quarterly revenue when it reports results on July 26.
* The Houston Texas-based company is expected to report a
8.7% increase in revenue to $131.46 million from $120.9 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data. The company's guidance on April 26
2023, for the period ended June 30, was for revenue between
$130.00 million and $135.00 million.
* Refinitiv's mean analyst estimate for Core Laboratories
Inc is
for earnings of 20 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Core
Laboratories
Inc is $21, below its last closing price of $24.68.
The company's guidance on April 26 2023 for the period ended
June 30 was for Earnings before Interest and Taxes between
USD14.5 million and USD17.5 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.16 0.16 0.19 Beat 20.3
Dec. 31 2023 0.19 0.20 0.20 Met 2.2
Sep. 30 2022 0.15 0.15 0.18 Beat 20.3
Jun. 30 2022 0.12 0.14 0.12 Missed -12
Mar. 0.07 0.09 0.08 Missed -11.6
31 2022
Dec. 31 2021 0.20 0.20 0.20 Met -0.4
Sep. 30 2021 0.18 0.19 0.18 Missed -3.8
Jun. 30 2021 0.19 0.19 0.18 Missed -6.2
This summary was machine generated July 25 at 02:01 GMT. All
figures in US dollars unless otherwise stated